|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales | |||||
| Cost of sales | |||||
| Gross margin | |||||
| Selling and administrative expense | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Other income, net | |||||
| Income from continuing operations before income taxes | |||||
| Income tax expense | |||||
| Net income from continuing operations | |||||
| Loss from discontinued operations, net of income taxes | |||||
| Net income | |||||
| Net income attributable to noncontrolling interests | |||||
| Net income attributable to Avient common shareholders | |||||
| Continuing operations (in usd per share) | |||||
| Discontinued operations (in usd per share) | |||||
| Earnings per share attributable to Avient common shareholders - Basic (in USD per share) | |||||
| Earnings per share attributable to Avient common shareholders - Diluted (in USD per share) | |||||
| Weighted-average shares used to compute earnings per common share: | |||||
| Basic (in shares) | |||||
| Plus dilutive impact of share-based compensation (in shares) | |||||
| Diluted (in shares) | |||||
| Anti-dilutive shares not included in diluted common shares outstanding (in shares) | |||||
| Cash dividends declared per share of common stock (in USD per share) |
Loading...
